Inpharma Weekly

, Volume 1470, Issue 1, pp 14–14 | Cite as

PEG IFN-α-2b effective against HBeAg+ hepatitis B

Clinical study
  • 4 Downloads

Keywords

Lamivudine Monotherapy Recipient PegIntron Combination Therapy Recipient Serum HBeAg 

Copyright information

© Adis International Ltd 2005

Personalised recommendations